PYRIDONE MEDICINAL PRODUCTS AS FOCAL ACCESSION CHINESE (FAK) INHIBITORS AND THEIR USE FOR THE TREATMENT OF CRABS

• 1. 酪氨酸激酶抑制剂联合长春碱类药物在制备预防或治疗肿瘤疾病的药物中的用途 [P] . 中国专利： CN111821304A . 2020-10-27
• 2. 作为黏着斑激酶(FAK)抑制剂的吡啶酮酰胺衍生物和它们治疗癌症的用途 [P] . 中国专利： CN101784538A . 2010-07-21
• 3. Pyridone amide derivatives as focal adhesion kinase (FAK) inhibitors and their use for the treatment of cancer [P] . 日本专利： JP2010536813A . 2010-12-02

  机译： 吡啶酮酰胺衍生物作为粘着斑激酶（FAK）抑制剂及其在治疗癌症中的用途

• 4. PYRIDONAMIDE DERIVATIVES AS FOCAL ADHESION KINASE (FAK) INHIBITORS AND THEIR USE FOR THE TREATMENT OF CANCER [P] . AT500245T . 2011-03-15

  机译： 吡DON酰胺衍生物作为局灶性粘附激酶（FAK）抑制剂及其在癌症治疗中的用途

• 5. DERIVATIVES OF PIRIDONAMIDE AS INHIBITORS OF THE FOCAL ADHESION TAPE (FAK) AND ITS EMPLOYMENT FOR THE TREATMENT OF CANCER. [P] . ES2360162T3 . 2011-06-01

  机译： 吡那酰胺作为局灶性胶粘带（FAK）抑制剂的衍生物及其在癌症治疗中的应用。

• 1. Changes in Net Barter Terms of Trade for Sino-Australian Agricultural Products after China’s Accession to the WTO [J] . Beibei WANG, Haifeng XIAO 亚洲农业研究：英文版 . 2015,第012期
• 2. Ministry of Information Industry:A Catalogue of Tariff Reduction on IT Products for China’s WTO Accession [J] . 中国对外贸易：英文版 . 2002,第002期
• 3. A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl) -3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1 3,7]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo [J] . GolubovskayaV.M., FigelS., HoB.T., Carcinogenesis . 2012,第5期
• 4. A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl) -3, 5, 7-triaza-1-azoniatricyclon [3.3.1.13,7]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicityn and tumor growth in vivo [J] . Carcinogenesis . 2012,第5期
• 5. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors [J] . Marlowe Timothy A., Lenzo Felicia L., Figel Sheila A., Molecular cancer therapeutics . 2016,第12期
• 6. Optimization of Crab Flavoring Extraction by Means of Enzyme Processing Aids from Chinese Mitten Crab (Eriocheir Sinensis) By-products Using Response Surface Methodology (RSM) [C] . Wang Jue, Wang Xi-chang, Liu Yuan International Conference on Measurement, Instrumentation and Automation . 2013
• 7. A small molecule focal adhesion kinase (FAK) inhibitor targeting Y397 site: 1-(2-hydroxyethyl) -3 5 7-triaza-1-azoniatricyclo 3.3.1.137decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability clonogenicity and tumor growth in vivo [O] . Vita M. Golubovskaya, Sheila Figel, Baotran T. Ho, -1
• 8. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors [O] . Timothy A. Marlowe, Felicia L. Lenzo, Sheila A. Figel, 2016

• 1. Focal adhesion kinase-related non-kinase ameliorates liver fibrosis by inhibiting aerobic glycolysis via the FAK/Ras/c-myc/ENO1 pathway [J] . Tao Huang ,Yuan-Qing-Xiao Li ,Ming-Yu Zhou . 世界胃肠病学杂志:英文版 . 2022,第1期
• 2. Screening the active constituents of Chinese medicinal herbs as potent inhibitors of Cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34^(cdc2) kinase [J] . 杨骅 ,郑树 ,MEIJER Laurent . 浙江大学学报（英文版）B辑：生物医学与生物技术 . 2005,第7期
• 3. Globalization of Traditional Chinese Medicinal products And New Regulatory Structures in the European Union [J] . Emiel Van Galen ,Burt Kroes . 世界科学技术-中医药现代化 . 2009,第001期
• 4. 生长因子受体酪氨酸酶抑制剂(TKI)类药物维持治疗疗效的meta分析 [C] . 臧嘉捷 ,贺佳 . 中华医学会临床流行病学分会首届年度学术论坛(上海) . 2011
• 5. 1贝特类药物在2型糖尿病患者调脂治疗中的作用；2DPP-4抑制剂与GLP-1受体激动剂对2型糖尿病患者血脂的影响 [A] . 吴杭 . 2014